ID

29251

Beschreibung

Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01006291

Link

https://clinicaltrials.gov/show/NCT01006291

Stichworte

Versionen (1)
  1. 12.03.18 12.03.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

12. März 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes NCT01006291

Englisch

Eligibility Diabetes NCT01006291

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01006291
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus (diagnosed clinically) for at least 6 months
Beschreibung

Non-Insulin-Dependent Diabetes Mellitus Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
current treatment: oral anti-diabetic drug(s) (oad(s)) alone, basal insulin alone or the combination of oad(s) and basal insulin. allowed oads are: metformin, insulin secretagogues (sulphonylureas (su) or glinides), pioglitazone with unchanged dosing for at least 3 months prior to visit 1
Beschreibung

Antidiabetics Oral Dose unchanged | Basal insulin | Combined Modality Therapy | Metformin | Pills Insulin Releasing | Sulfonylurea | Glinides | pioglitazone

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0442739
UMLS CUI [2]
C0650607
UMLS CUI [3]
C0009429
UMLS CUI [4]
C0025598
UMLS CUI [5,1]
C0994475
UMLS CUI [5,2]
C0021641
UMLS CUI [5,3]
C1283071
UMLS CUI [6]
C0038766
UMLS CUI [7]
C3537178
UMLS CUI [8]
C0071097
hba1c: oads only users 7.0-11.0 % (both inclusive), basal insulin with/without oads users 7.0-10.0% (both inclusive) by central laboratory analysis
Beschreibung

Glucohemoglobin measurement | Antidiabetics Oral | Basal insulin

Datentyp

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3]
C0650607
body mass index (bmi) below or equal to 40.0 kg/m^2
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
cancer and medical history of cancer hereof
Beschreibung

Malignant Neoplasms

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
use within the last 3 months prior to visit 1 of: glucagon-like peptide-1(glp-1) receptor agonist (exenatide, liraglutide), rosiglitazone, dipeptidyl peptidase iv (dpp-iv) inhibitors, alpha-glucosidase-inhibitors
Beschreibung

GLP-1 Receptor Agonist | exenatide | liraglutide | rosiglitazone | Dipeptidyl Peptidase 4 Inhibitors | alpha-Glucosidase Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C2917359
UMLS CUI [2]
C0167117
UMLS CUI [3]
C1456408
UMLS CUI [4]
C0289313
UMLS CUI [5]
C2917254
UMLS CUI [6]
C1299007
cardiovascular disease, within the last 6 months prior to visit 1, defined as: stroke; decompensated heart failure new york heart association (nyha) class iii or iv; myocardial infarction; unstable angina pectoris; or coronary arterial bypass graft or angioplasty
Beschreibung

Cardiovascular Disease | Cerebrovascular accident | Decompensated cardiac failure New York Heart Association Classification | Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery | Angioplasty

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0038454
UMLS CUI [3,1]
C0581377
UMLS CUI [3,2]
C1275491
UMLS CUI [4]
C0027051
UMLS CUI [5]
C0002965
UMLS CUI [6]
C0010055
UMLS CUI [7]
C0162577
uncontrolled treated/untreated severe hypertension (systolic blood pressure at least 180 millimetre (mm) mercury (hg) and/or diastolic blood pressure at least 100 mmhg)
Beschreibung

Severe Hypertension Uncontrolled Treated | Severe Hypertension Uncontrolled untreated | Systolic Pressure | Diastolic blood pressure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4013784
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C1522326
UMLS CUI [2,1]
C4013784
UMLS CUI [2,2]
C0205318
UMLS CUI [2,3]
C0332155
UMLS CUI [3]
C0871470
UMLS CUI [4]
C0428883
pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures according to local requirements
Beschreibung

Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0700589
UMLS CUI [4,2]
C0332197
cancer and medical history of cancer hereof (except basal cell skin cancer and squamous cell skin cancer)
Beschreibung

Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes NCT01006291

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01006291
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes mellitus (diagnosed clinically) for at least 6 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Antidiabetics Oral Dose unchanged | Basal insulin | Combined Modality Therapy | Metformin | Pills Insulin Releasing | Sulfonylurea | Glinides | pioglitazone
Item
current treatment: oral anti-diabetic drug(s) (oad(s)) alone, basal insulin alone or the combination of oad(s) and basal insulin. allowed oads are: metformin, insulin secretagogues (sulphonylureas (su) or glinides), pioglitazone with unchanged dosing for at least 3 months prior to visit 1
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0442739 (UMLS CUI [1,4])
C0650607 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
C0994475 (UMLS CUI [5,1])
C0021641 (UMLS CUI [5,2])
C1283071 (UMLS CUI [5,3])
C0038766 (UMLS CUI [6])
C3537178 (UMLS CUI [7])
C0071097 (UMLS CUI [8])
Glucohemoglobin measurement | Antidiabetics Oral | Basal insulin
Item
hba1c: oads only users 7.0-11.0 % (both inclusive), basal insulin with/without oads users 7.0-10.0% (both inclusive) by central laboratory analysis
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0650607 (UMLS CUI [3])
Body mass index
Item
body mass index (bmi) below or equal to 40.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms
Item
cancer and medical history of cancer hereof
boolean
C0006826 (UMLS CUI [1])
GLP-1 Receptor Agonist | exenatide | liraglutide | rosiglitazone | Dipeptidyl Peptidase 4 Inhibitors | alpha-Glucosidase Inhibitors
Item
use within the last 3 months prior to visit 1 of: glucagon-like peptide-1(glp-1) receptor agonist (exenatide, liraglutide), rosiglitazone, dipeptidyl peptidase iv (dpp-iv) inhibitors, alpha-glucosidase-inhibitors
boolean
C2917359 (UMLS CUI [1])
C0167117 (UMLS CUI [2])
C1456408 (UMLS CUI [3])
C0289313 (UMLS CUI [4])
C2917254 (UMLS CUI [5])
C1299007 (UMLS CUI [6])
Cardiovascular Disease | Cerebrovascular accident | Decompensated cardiac failure New York Heart Association Classification | Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery | Angioplasty
Item
cardiovascular disease, within the last 6 months prior to visit 1, defined as: stroke; decompensated heart failure new york heart association (nyha) class iii or iv; myocardial infarction; unstable angina pectoris; or coronary arterial bypass graft or angioplasty
boolean
C0007222 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0581377 (UMLS CUI [3,1])
C1275491 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C0002965 (UMLS CUI [5])
C0010055 (UMLS CUI [6])
C0162577 (UMLS CUI [7])
Severe Hypertension Uncontrolled Treated | Severe Hypertension Uncontrolled untreated | Systolic Pressure | Diastolic blood pressure
Item
uncontrolled treated/untreated severe hypertension (systolic blood pressure at least 180 millimetre (mm) mercury (hg) and/or diastolic blood pressure at least 100 mmhg)
boolean
C4013784 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C4013784 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0332155 (UMLS CUI [2,3])
C0871470 (UMLS CUI [3])
C0428883 (UMLS CUI [4])
Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Absent
Item
pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures according to local requirements
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
cancer and medical history of cancer hereof (except basal cell skin cancer and squamous cell skin cancer)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video